Markets Overview

The S&P 500 (^GSPC) is down roughly 7% year-to-date, with more than half of its industry sectors already in correction territory — raising the question of when the broad index itself will officially cross that threshold. The Nasdaq Composite (^IXIC) has fared worse, falling close to 9% from its recent highs and formally entering correction territory. The 200-day moving average, Wall Street's go-to technical indicator, is losing its predictive edge as ETF-driven flows distort traditional signals, according to MarketWatch. Bank stocks have shown modest resilience, ticking up about 2% over the past two weeks per the KBW Nasdaq Bank Index, but the overall market tone remains defensive as investors weigh geopolitical risk, sticky inflation, and slowing growth.

Earnings Reports

Carnival (CCL) beat estimates in its fiscal Q1 report but shares still headed lower, weighed down by the fallout from the Iran conflict disrupting cruise operations and travel sentiment. Progressive (PGR) faces a pivotal stretch after an extraordinary run that saw EPS ramp from roughly $1 in 2022 to nearly $20 in 2025 — the hard insurance market that fueled those gains is now softening, making the next leg harder to sustain. IREN (IREN) is drawing analyst debate despite a $9.7 billion Microsoft data center contract, with its premium valuation leaving zero margin for execution missteps. Argan (AGX) spiked after reporting stronger-than-expected quarterly profits, benefiting from its engineering and power infrastructure positioning. MercadoLibre (MELI), down from its highs, is drawing bargain-hunting interest given its 5,500% return since IPO — though the Latin American macro backdrop remains tricky. Cava Group (CAVA) is pushing ahead with aggressive restaurant expansion despite volatile conditions, with shares having traded in the mid-$60s back in January.

Fed & Economic Data

Fed Chair Jerome Powell signaled growing concern about an inflation resurgence following the latest FOMC meeting, where the Fed held rates steady — marking a second consecutive meeting where Powell appeared to lay inflation risks partly at the feet of administration policy. The combination of tariffs, surging energy costs from the Iran conflict, and slowing GDP growth has created a stagflationary backdrop that has the Fed boxed in. Recession odds have hit their highest level in years, though history shows the S&P 500 has often recovered from similar alarm signals. The Trump-Fed feud is expected to intensify as $100+ oil prices flow through to inflation prints in coming months, potentially delaying any rate cuts the market had been hoping for.

Hot Sectors

Energy is the dominant theme as the Iran conflict has effectively disrupted the Strait of Hormuz, driving oil above $100 and creating the biggest supply shock in decades — investors are rotating into names with direct commodity exposure. Semiconductors remain a consensus long-term buy on AI demand, with U.S. hyperscalers planning over $700 billion in data center spending for 2026 alone, though near-term sentiment is fragile. AI stocks broadly have struggled under the weight of geopolitical uncertainty, high valuations, and questions about the pace of spending returns. Elon Musk's newly announced "Terafab" concept is generating buzz around next-generation manufacturing scale, with Tesla and adjacent plays drawing attention. Renewables vs. traditional energy is emerging as a key allocation debate, with Brookfield Renewable and Enterprise Products Partners representing opposite ends of the energy spectrum as oil prices reshape the calculus.

Stock News

Berkshire Hathaway (BRK.A, BRK.B) remains the one clear buy for Warren Buffett — the Oracle of Omaha was a net seller for 13 consecutive quarters before stepping down as CEO at year-end 2025, but Berkshire's own stock continues to be his conviction pick. Beyond Meat (BYND) is fighting for survival with shares a fraction of their former $230 peak, and a reverse stock split is increasingly likely to maintain its listing. Eli Lilly (LLY) is down 15% year-to-date despite its weight-loss drug dominance, as investors fret about eventual competitive threats. Gecko Robotics, still pre-IPO, landed its biggest-ever Navy contract — a notable signal for the defense-tech pipeline. Several insider sales caught attention: Enliven Therapeutics' (ELVN) CMO sold 40,000 shares for $1.2 million, Alphatec's (ATEC) EVP unloaded $1.4 million in stock, and Curbline Properties' (CURB) CEO sold $3 million in shares.

Market Analysis

The overarching narrative is a market caught between three colliding forces: a geopolitical shock (Iran conflict and $100+ oil), a stubborn Fed unwilling to cut into inflationary crosswinds, and an economy showing signs of deceleration with slow job gains and softening GDP. History offers some comfort — corrections of this magnitude have typically been followed by recoveries — but the macro setup is more complex than a garden-variety pullback. The Roth 401(k) RMD elimination is quietly reshaping retirement strategy, and dividend-focused ETFs like Schwab U.S. Dividend Equity ETF (SCHD) are seeing heavy inflows as investors seek defensiveness, raising crowding concerns. Watch next week for any signals on Iran de-escalation, incoming inflation data that will reflect the oil shock, and whether the S&P 500 officially crosses the 10% correction line. In this environment, cash-rich balance sheets, pricing power, and energy exposure are the portfolio attributes earning their keep.